evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
5868,GENE_BACKGROUND,,"The AXIN1 gene encodes Axis Inhibition Protein 1, a key component of the beta-catenin (CTNNB1) destruction complex. Negative regulation of beta-catenin by the complex in the absence of an extracellular stimulus is central to WNT signaling (PMID: 20128690, 23169527). In the complex, AXIN1 and AXIN2 provide scaffolding and bind to the tumor suppressor APC (PMID: 14600025) enabling CTNNB1 destruction (PMID: 9734785). AXIN1 is involved in the TGFβ and SAPK pathways (PMID: 15735151). As part of the AXIN-HIPK2-TP53 complex, the protein also plays a role in the control of cell growth, apoptosis and development (PMID: 15526030). Truncating somatic mutations in this gene, typical of a tumor suppressor, have been associated with hepatocellular carcinoma and hepatoblastomas. Germline mutations in AXIN1 have been associated with gastrointestinal cancers (PMID: 25236910). DNA hypermethylation of the AXIN1 promoter has been associated with caudal duplication anomaly (PMID: 16773576). No drugs targeting the Wnt pathway have yet been approved (PMID: 24981364) although there is some preclinical evidence of disruption of AXIN1 interactions (PMID: 21826110).",,2017-03-22,,8312,AXIN1,axin 1,False,ENST00000262320,NM_003502.3,AXIN,PPP1R49,True,15526030,Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.,The EMBO journal,2017-11-24T20:04:00,23,23,4583-94,Rui Y et al,,,0001-11-24,,25236910,AXIN1 and AXIN2 variants in gastrointestinal cancers.,Cancer letters,2017-12-01T20:14:00,355,True,2001-01-08,Mazzoni SM et al,doi: 10.1016/j.canlet.2014.09.018,,0001-12-01,,23169527,The β-catenin destruction complex.,Cold Spring Harbor perspectives in biology,2018-01-01T20:13:00,5,True,a007898,Stamos JL et al,doi: 10.1101/cshperspect.a007898,,0001-01-01,,20128690,MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway.,Biological chemistry,2018-02-01T20:10:00,391,2001-02-03,171-80,Sue Ng S et al,doi: 10.1515/BC.2010.028,,2001-02-03,,15735151,The links between axin and carcinogenesis.,Journal of clinical pathology,2018-03-01T20:05:00,58,3,225-36,Salahshor S et al,,,0001-03-01,,16773576,Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly.,American journal of human genetics,2018-07-01T20:06:00,79,True,155-62,Oates NA et al,,,0001-07-01,,24981364,Can we safely target the WNT pathway?,Nature reviews. Drug discovery,2018-07-01T20:14:00,13,7,513-32,Kahn M,doi: 10.1038/nrd4233,,0001-07-01,,14600025,Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.,Genes &amp; development,2018-11-15T20:03:00,17,22,2753-64,Xing Y et al,,,0001-11-15,,21826110,Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation.,Cell research,2018-01-01T20:12:00,22,True,237-47,Gwak J et al,doi: 10.1038/cr.2011.127,,0001-01-01,,9734785,"Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.",Genes to cells : devoted to molecular &amp; cellular mechanisms,0001-06-01,3,6,395-403,Nakamura T et al,,,2018-06-01T04:03:00,
5867,GENE_SUMMARY,,"AXIN1, a tumor suppressor involved in WNT signaling, is mutated at low frequencies in a diverse range of cancers.",,2017-10-23,,8312,AXIN1,axin 1,False,ENST00000262320,NM_003502.3,AXIN,PPP1R49,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
